ATE499093T1 - Zusammensetzung auf citicolin-basis in kombination mit vitaminen zur prävention und behandlung von augenerkrankungen - Google Patents

Zusammensetzung auf citicolin-basis in kombination mit vitaminen zur prävention und behandlung von augenerkrankungen

Info

Publication number
ATE499093T1
ATE499093T1 AT04791899T AT04791899T ATE499093T1 AT E499093 T1 ATE499093 T1 AT E499093T1 AT 04791899 T AT04791899 T AT 04791899T AT 04791899 T AT04791899 T AT 04791899T AT E499093 T1 ATE499093 T1 AT E499093T1
Authority
AT
Austria
Prior art keywords
citicoline
combination
vitamins
prevention
treatment
Prior art date
Application number
AT04791899T
Other languages
English (en)
Inventor
Chiara Barozzi
Original Assignee
Bausch & Lomb Iom S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch & Lomb Iom S P A filed Critical Bausch & Lomb Iom S P A
Application granted granted Critical
Publication of ATE499093T1 publication Critical patent/ATE499093T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04791899T 2003-10-22 2004-10-14 Zusammensetzung auf citicolin-basis in kombination mit vitaminen zur prävention und behandlung von augenerkrankungen ATE499093T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000485A ITRM20030485A1 (it) 2003-10-22 2003-10-22 Composizione a base di citicolina in associazione con vitamine per la prevenzione ed il trattamento di patolgie oculari.
PCT/IT2004/000565 WO2005037262A1 (en) 2003-10-22 2004-10-14 Citicoline-based composition in combination with vitamins for the prevention and treatment of eye pathologies

Publications (1)

Publication Number Publication Date
ATE499093T1 true ATE499093T1 (de) 2011-03-15

Family

ID=30131627

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04791899T ATE499093T1 (de) 2003-10-22 2004-10-14 Zusammensetzung auf citicolin-basis in kombination mit vitaminen zur prävention und behandlung von augenerkrankungen

Country Status (6)

Country Link
EP (1) EP1677774B1 (de)
AT (1) ATE499093T1 (de)
DE (1) DE602004031540D1 (de)
ES (1) ES2360221T3 (de)
IT (1) ITRM20030485A1 (de)
WO (1) WO2005037262A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1951071A2 (de) * 2005-10-18 2008-08-06 Artmed S.r.l. Nutrazeutika- und pharmazeutikazusammensetzungen, die cholin als adjuvans enthalten, für die vorbeugung und behandlung von retinopathien und glaukom
EP1951308B1 (de) * 2005-11-25 2013-02-20 Gisela Susilo Kombinationspräparate enthaltend physiologische zellmembran-bestandteile, einschliesslich phosphatidylserin, cholin und ein pyrimidinnukleos/tid
ES2758554T3 (es) 2009-12-08 2020-05-05 Univ Case Western Reserve Aminoácidos gama para tratamiento de trastornos oculares
ITMI20121223A1 (it) * 2012-07-13 2014-01-14 Gregorio Fabio De Nuova composizione farmacologica comprendente citicolina in combinazione con glicerolo e/o acetazolamide
WO2020106746A1 (en) 2018-11-19 2020-05-28 Heh Research & Development Services, Inc. Biologic enhancement formulation
US12213952B1 (en) 2017-03-09 2025-02-04 Heh Research & Development Services, Inc. Biologic enhancement formulation
CN111840220B (zh) * 2020-08-19 2022-09-30 开封康诺药业有限公司 一种胞磷胆碱钠注射液及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2280093A1 (en) * 1997-02-04 1998-08-06 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
TW580397B (en) * 1997-05-27 2004-03-21 Takeda Chemical Industries Ltd Solid preparation
CA2374760A1 (en) * 1999-06-18 2000-12-28 Takeda Chemical Industries, Ltd. Quickly disintegrating solid preparations
WO2002030400A1 (fr) * 2000-10-06 2002-04-18 Takeda Chemical Industries, Ltd. Preparations solides
US6506412B2 (en) * 2000-11-29 2003-01-14 Sciencebased Health Treatment of dry eye syndrome
US6583152B2 (en) * 2001-04-30 2003-06-24 Dexgen Pharmaceuticals, Inc. Composition for reducing the risk or progression of cardiovascular diseases

Also Published As

Publication number Publication date
ITRM20030485A1 (it) 2005-04-23
WO2005037262A1 (en) 2005-04-28
EP1677774B1 (de) 2011-02-23
ITRM20030485A0 (it) 2003-10-22
EP1677774A1 (de) 2006-07-12
ES2360221T3 (es) 2011-06-02
DE602004031540D1 (de) 2011-04-07

Similar Documents

Publication Publication Date Title
Liang et al. Melatonin protects human retinal pigment epithelial (RPE) cells against oxidative stress
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
PT88985A (pt) Processo para a preparacao de composicoes farmaceuticas nasais e ou oftalmicas contendo azelastina
EP1478371A4 (de) Verfahren und produkte zur verbesserung der immunantworten mit imidazochinolin-verbindungen
WO2006082588A3 (en) Method and device for ophthalmic administration of active pharmaceutical ingredients
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
MXPA04011612A (es) Uso oftalmologico de roflumilasto para el tratamiento de enfermedades del ojo.
CY1112981T1 (el) Μεθοδος και συνθεση για την αγωγη της ρινιτιδας
ATE409176T1 (de) 1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungen
ES2092890T3 (es) Aplicacion del riluzol en el tratamiento de la enfermedad de parkinson y de los sindromes de parkinson.
AR020662A1 (es) Compuestos dihidrotiazoles policiclicos, procedimientos para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y lautilizacion de dichos compuestos para la preparacion de un medicamento.
PT1207756E (pt) Utilizacao de espinosade ou de uma formulacao que compreende espinosade
EP1507554A4 (de) Lactoferrin bei der behandlung maligner neoplasien und anderer hyperproliferativer erkrankungen
UY28311A1 (es) Suplemento dietetico y metodo para el tratamiento y prevención de úlceras en el tracto digestivo en equinos y otros animales.
ATE499093T1 (de) Zusammensetzung auf citicolin-basis in kombination mit vitaminen zur prävention und behandlung von augenerkrankungen
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
WO2007077203A3 (en) Triterpenequinone and triterpenephenol derivatives and their application for the treatment of tumors and parasitic diseases
WO2019040459A3 (en) Composition and nutritional supplement made therefrom
AR045745A1 (es) Fracciones de leche y preparaciones de leche para el tratamiento y/o prevencion de las enfermedades mediadas por cox-2
ATE447963T1 (de) Verwendung von lavendelöl zur prophylaxe und behandlung von somatisierungsstörungen und von posttraumatischer stresserkrankung
DE60008293D1 (de) Pharmazeutische zusammensetzung die einen no donor enthält und dessen therapeutische anwendung
BRPI0411427A (pt) formulações de agentes antiinflamatórios não-esteróides para o tratamento de angiogênese ocular patológica
NO20051159L (no) Preparater og fremgangsmater for behandling av sykdommer som viser feilsammensetting av aggregering av protein
WO2001028578A3 (en) A PHARMACEUTICAL COMPOSITION CONTAINING pGLU-GLU-PRO-NH2 AND METHOD FOR TREATING DISEASES AND INJURIES TO THE BRAIN, SPINAL CORD AND RETINA USING SAME
NO20044519L (no) Hyperforinderivater, anvendelse derav samt formuleringer som inneholder dem

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties